Pancreatic cancer is one of the deadliest forms of cancer. So any bit of progress on the pancreatic cancer front is a big deal. And researchers are happy to report they've found a chemotherapy drug that can help patients who have received surgery prevent a return of the disease for a longer period of time.

In a German study, participants who received Gemzar, or gemcitabine, lived an average of 13.4 months without their cancers coming back. Participants who did not receive the drug lived without the disease for 6.9 months. While the findings of this study may seem modest, they really are quite encouraging because pancreatic cancer is such a rapid killer, and patients with this disease have the worst chances of recovery.

This study, published in Wednesday's Journal of the American Medical Association, brings hope for the mere 20 percent of pancreatic cancer patients who are candidates for surgery. While surgery is the best hope for a cure, the disease still returns in the majority of cases -- so Gemzar is surely worth a shot.

It should be noted that some study authors report financial ties to Gemzar drugmaker Eli Lilly and Co. Researchers, however, report the firm had no influence in design or data interpretation.

For women with estrogen-driven breast cancer suffering the symptoms of menopause, being prescribed traditional hormone replacement therapy (HRT) is out of the question. The risks are simply too great in introducing any estrogen into the body. There are few alternatives and many women decide to suffer with hot flashes, flushes, night sweats and cold flashes, a clammy feeling, sporadic rapid heart beat, irritability, mood swings, sudden tears, insomnia, fatigue, feelings of anxiety, dread, apprehension, difficulty concentrating, disorientation, depression and mental confusion -- without any significant relief. One of the alternatives is personalized natural hormone replacement therapy that is individually mixed specific to each woman's needs.

According to Sydney Menopause Centre at Randwick's Royal Hospital for Women director Dr John Eden, who has diagnosed two women patients with uterine cancer, believes the cancer is linked to natural hormone replacement therapy. Australian doctors are warning women to think twice before taking handmade hormone compounds prepared by chemists, due to the danger that these preparations can lead to elevated hormone levels that could lead to excessive bleeding, increased risk of breast and uterine cancer and blood clots.

"Many women think they are getting a herbal treatment and are shocked to learn they are getting a hormone treatment," stated Dr Eden. Dr Helena Teede, research director at the Jean Hailes Foundation, also added that many women were unaware these preparations were not approved by the Therapeutic Goods Administration.

Quick autopsies -- or rapid organ donation -- may steer scientists in the direction of better diagnosing and treating the most lethal of cancers. Some 33,700 Americans will be diagnosed with pancreatic cancer this year -- and 32,300 will die. There is no early detection test for this disease and early symptoms are vague and may be mistaken for health concerns like indigestion. By the time the classic symptoms -- jaundice and itching -- surface, the cancer has typically spread and patients have only months to live. Rapid autopsies have been used before -- for Alzheimer's and prostate cancer -- but this a first in the study of pancreatic cancer and it just may lead to the discovery of what makes this cancer so aggressive and so deadly.